dibutyryl cyclic-3',5'-cytidine monophosphate and angiotensin ii

dibutyryl cyclic-3',5'-cytidine monophosphate has been researched along with angiotensin ii in 2 studies

Compound Research Comparison

Studies (dibutyryl cyclic-3',5'-cytidine monophosphate)	Trials (dibutyryl cyclic-3',5'-cytidine monophosphate)	Recent Studies (post-2010) (dibutyryl cyclic-3',5'-cytidine monophosphate)	Studies (angiotensin ii)	Trials (angiotensin ii)	Recent Studies (post-2010) (angiotensin ii)
72	0	18	38,152	1,089	7,413

Protein Interaction Comparison

Protein	Taxonomy	angiotensin ii (IC50)
Atrial natriuretic peptide receptor 3	Homo sapiens (human)	0.002
Type-1A angiotensin II receptor	Rattus norvegicus (Norway rat)	0.002
Type-1B angiotensin II receptor	Rattus norvegicus (Norway rat)	0.0018
Type-1 angiotensin II receptor	Homo sapiens (human)	0.0055
Type-2 angiotensin II receptor	Rattus norvegicus (Norway rat)	0.004
Type-2 angiotensin II receptor	Homo sapiens (human)	0.0011

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	2 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Borrajo, A; Diaz-Ruiz, C; Guerra, MJ; Labandeira-Garcia, JL; Rodriguez-Perez, AI	1
Carretero, OA; Garvin, JL; Ortiz, PA; Ramseyer, VD	1

Other Studies

2 other study(ies) available for dibutyryl cyclic-3',5'-cytidine monophosphate and angiotensin ii

Article	Year
Microglial TNF-α mediates enhancement of dopaminergic degeneration by brain angiotensin. Glia, 2014, Volume: 62, Issue:1 Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Cells, Cultured; Cyclic CMP; Dopaminergic Neurons; Dose-Response Relationship, Drug; Enzyme Inhibitors; Kallikreins; Male; Mesencephalon; Mice; Mice, Inbred C57BL; Microglia; Nerve Degeneration; Neurons; Neurotoxins; Pancreatic Extracts; Tetrazoles; Tumor Necrosis Factor-alpha	2014
Angiotensin II-mediated hypertension impairs nitric oxide-induced NKCC2 inhibition in thick ascending limbs. American journal of physiology. Renal physiology, 2016, 04-15, Volume: 310, Issue:8 Topics: Angiotensin II; Animals; Cyclic CMP; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 5; Endothelin-1; Hypertension; Loop of Henle; Male; Nitric Oxide; Nitric Oxide Donors; Phosphodiesterase 5 Inhibitors; Rats; Rats, Sprague-Dawley; Solute Carrier Family 12, Member 1; Vardenafil Dihydrochloride	2016

Article

Year

Microglial TNF-α mediates enhancement of dopaminergic degeneration by brain angiotensin.

Glia, 2014, Volume: 62, Issue:1

Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Benzimidazoles; Biphenyl Compounds; Cells, Cultured; Cyclic CMP; Dopaminergic Neurons; Dose-Response Relationship, Drug; Enzyme Inhibitors; Kallikreins; Male; Mesencephalon; Mice; Mice, Inbred C57BL; Microglia; Nerve Degeneration; Neurons; Neurotoxins; Pancreatic Extracts; Tetrazoles; Tumor Necrosis Factor-alpha

2014

Angiotensin II-mediated hypertension impairs nitric oxide-induced NKCC2 inhibition in thick ascending limbs.

American journal of physiology. Renal physiology, 2016, 04-15, Volume: 310, Issue:8

Topics: Angiotensin II; Animals; Cyclic CMP; Cyclic GMP; Cyclic Nucleotide Phosphodiesterases, Type 5; Endothelin-1; Hypertension; Loop of Henle; Male; Nitric Oxide; Nitric Oxide Donors; Phosphodiesterase 5 Inhibitors; Rats; Rats, Sprague-Dawley; Solute Carrier Family 12, Member 1; Vardenafil Dihydrochloride

2016